knowledge -WSS

knowledge

author：leisure time 2025-09-06 10:59:13 - browse：9122

Moderna chairman Noubar Afeyan exuded star power earlier this month as he commanded the spotlight at BIO 2023, the industry’s largest convention.

Basking in the accolades heaped on Moderna’s celebrated Covid-19 vaccine, Afeyan regaled the Boston audience with the company’s origin story and greeted fans who lined up to snap selfies with him. Stuart Cable, a partner in the law firm Goodwin who’s represented Moderna and joined Afeyan on stage, called Moderna “arguably the most successful story in the history of biotechnology.”

But the Cambridge, Mass.-based company can’t afford to rest on its laurels. Two and a half years after its vaccine liberated tens of millions from pandemic lockdowns — ringing up more than $36 billion in sales so far — Moderna faces a changing business and regulatory environment. Demand for Covid shots is waning, a backlash over drug prices is gaining traction, and questions about its next act loom.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Dario to buy mental health app maker Twill in cash and stock deal

leisure time

WSS

An outrageous hospital charge: I paid $710 for an hour of babysitting

Ed Silverman on new gene therapies, biosimilars, coffee, and more

Bryan Kohberger seeks indictment dismissal in Idaho college killings case

Ed Silverman on new gene therapies, biosimilars, coffee, and more

Trump lawyers meet with special counsel in Jan. 6 case as potential indictment looms

A new nitrogen execution bill also undermines medical licensing

hotspot

knowledge

focus

The cancer drug shortage isn’t new — and neither are the solutions

Ed Silverman on new gene therapies, biosimilars, coffee, and more

How to save PrEP access — and even expand it

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

United colonoscopy coverage change 'may cost lives,' doctors say

Marc Tessier

How to save PrEP access — and even expand it

STAT readers on older presidents, polypills, Medicare, and more

Anesthesiologist group: stop taking Ozempic before surgery

Alexander Hamilton and the argument for universal insurance

hotspot

New documents shed light on MD Anderson Cancer Institute feud

Biden to sign 'historic' executive order on how US military handles sexual assault cases

New documents shed light on MD Anderson Cancer Institute feud

Will biotech layoffs continue through 2023?

Alexander Hamilton and the argument for universal insurance

A new nitrogen execution bill also undermines medical licensing

leisure time

focus

entertainment

focus